Ropes & Gray and Luthra & Luthra have represented private equity firm The Carlyle Group in its acquisition of a 37 percent stake in Metropolis Healthcare, an India-based global operator of pathology laboratories.
A Carlyle Group unit purchased the stake from former Metropolis promoter Dr. GSK Velu and his affiliates, who were counseled by Khaitan and Company and Shardul Amarchand Mangaldas & Co.
Carlyle and Metropolis, which has branches across several countries including Sri Lanka, United Arab Emirates and South Africa, didn’t disclose financial details of the sale. A source familiar with the matter estimated that Carlyle's investment was worth around $150 million to $200 million, according to Reuters
A team from Ropes & Gray’s Hong Kong office handled the transaction, led by PE partners Scott Jalowayski and Michael Nicklin. Partner Kim Nemirow handled government enforcement aspects of the deal.
Luthra & Luthra’s team was headed by senior partner Mohit Saraf and Bikash Jhawar. Suyash Srivastava was involved in employment issues while Gayatri Roy reviewed trademark and other IP concerns.
The firm had also earlier advised Carlyle in its acquisition of stake in Medanta Hospital, located in Delhi NCR.
